NASDAQ:EVAX Evaxion A/S Q3 2026 Earnings Date & Estimates $3.76 +0.05 (+1.35%) Closing price 10/23/2026 04:00 PM EasternExtended Trading$3.86 +0.10 (+2.63%) As of 10/23/2026 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Evaxion A/S is estimated to report Q3 2026 earnings on Thursday, November 19, 2026, before market opens. The conference call is scheduled for 12:30 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 19, 2026TimeBefore Market OpensConference Call12:30 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Evaxion A/S in Q3 2026Evaxion A/S is expected to post earnings of -$0.01 per share on revenue of $0.30 million. Evaxion A/S last reported on May 7, 2026, posting -$0.44 per share and missing the -$0.01 consensus estimate. Evaxion A/S has beaten the consensus EPS estimate in 4 of its last 8 quarters.Consensus EstimatesConsensus EPS-$0.01Expected Revenue$0.30 millionRecent Track RecordLast ReportedQ1 2026Last Quarter EPS-$0.44 (Missed by -$0.43)EPS Beat Rate4 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ1 2026 Earnings ReportQ2 2025 Earnings ReportQ1 2025 Earnings Report Evaxion A/S Q3 2026 Earnings FAQ When does Evaxion A/S report Q3 2026 earnings? Evaxion A/S (NASDAQ:EVAX) is estimated to report Q3 2026 earnings on Thursday, November 19, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it. What time is Evaxion A/S' Q3 2026 earnings call? Evaxion A/S' Q3 2026 earnings conference call is scheduled for Thursday, November 19, 2026 at 12:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Evaxion A/S? Analysts expect Evaxion A/S to post earnings of -$0.01 per share for Q3 2026. How much revenue is Evaxion A/S expected to report? The consensus revenue estimate for Evaxion A/S is $0.30 million for Q3 2026. When is Evaxion A/S' next earnings date? Evaxion A/S' next earnings date is estimated for Thursday, November 5, 2026. MarketBeat tracks confirmed and estimated earnings dates for Evaxion A/S on the company's earnings history page. Evaxion A/S Earnings HeadlinesEvaxion Biotech (EVAX) Gets a Buy from Maxim GroupOctober 23 at 6:58 PM | theglobeandmail.comEVAX stock heads for best week since January 2025 as cancer vaccine shows 89% target precisionOctober 23 at 8:00 AM | msn.comEarth's biggest energy source: near Grand CanyonThe largest energy source on Earth contains 50,000 times every oil and gas reserve on the planet combined - and much of it sits beneath the desert near the Grand Canyon. A drilling crew just hit the DOE's 2035 targets twelve years early, with costs down 50% in 18 months. Google signed on, Gates invested, and the Pentagon made it a priority. One company has been quietly building this infrastructure for sixty years.October 25 at 1:00 AM | Behind the Markets (Ad)Evaxion announces 89% vaccine target precision and sustained T-cell and clinical responses at three-year follow-up in phase 2 trial with personalized cancer vaccine EVX-01October 23 at 2:00 AM | globenewswire.comEvaxion A/S - Sponsored ADR (EVAX) - What Are Researchers Thinking About This Stock?October 22 at 1:44 AM | americanbankingnews.comAnalysts Offer Insights on Healthcare Companies: AgomAb Therapeutics NV ADR (AGMB) and Evaxion Biotech (EVAX)October 21, 2026 | theglobeandmail.comSee More Evaxion A/S Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Evaxion A/S? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Evaxion A/S and other key companies, straight to your email. Email Address About Evaxion A/SEvaxion A/S (NASDAQ:EVAX) is a Denmark-based biotechnology company developing artificial intelligence-driven immunotherapies. The company’s technology is designed to identify disease-specific targets, known as antigens, and support the development of personalized treatments that stimulate a patient’s immune system to recognize and attack diseased cells or pathogens. Evaxion’s research programs have focused primarily on personalized cancer immunotherapies, including EVX-01, as well as vaccines and immunotherapies for infectious diseases caused by bacteria and viruses. Its AI-Immunology platform is intended to analyze biological data, predict relevant immune targets and help design candidate therapies more efficiently than conventional discovery methods. Founded in Denmark, Evaxion has conducted research and development activities through collaborations with biotechnology and pharmaceutical organizations and has pursued clinical development of its cancer programs. The company’s American depositary shares began trading on the Nasdaq Capital Market in 2021. Evaxion is headquartered in Copenhagen, Denmark, and has been led by Chief Executive Officer Per Norlén.View Evaxion A/S ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 10/19 - 10/23Amex Stock Slides on Job Cuts, But the Real Story Is MacroBloom Energy Just Reported—Its Biggest Order Is Still Waiting on a PipelineNewmont’s Record Quarter Shows Why Gold’s Floor Is the Real StoryLockheed Martin’s Record $292 Billion Backlog Comes With a Delivery TestCan Planet Fitness Get Its Growth Back in Shape?Spotify Soars After Earnings as the Company Touts AI Benefits and Moderating Costs Upcoming Earnings Verizon Communications (10/26/2026)Nucor (10/26/2026)Public Storage (10/26/2026)Welltower (10/26/2026)Cadence Design Systems (10/26/2026)Hilton Worldwide (10/27/2026)Royal Caribbean Cruises (10/27/2026)CocaCola (10/27/2026)Coca Cola Femsa (10/27/2026)Baker Hughes (10/27/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
